Breaking News Instant updates and real-time market news.

2022-07-07 07:11:39 ADVM Adverum Biotechnologies $1.23 / +0.045 (+3.81%) 07:11 07/07/22 07/07 07:11 07/07/22 07:11	Truist upgrades Adverum to Buy on 'clearer development path' Truist analyst Joon Lee upgraded Adverum Biotechnologies to Buy from Hold with a price target of $4, up from $3. The analyst now sees a "clearer development path" for ixoberogene soroparvovec in wet age-related macular degeneration. The Phaser 2 LUNA trial will dose first patient in Q3 with stream of data readouts throughout 2023, Lee tells investors in a research note. In addition, Adverum's cash runway has been extended by one year into 2025 post its restructuring, says the analyst. Lee is "relieved" to see the company's agreement with both the FDA and the European Medicines Agency on the Phase 2 trial design.	21 Jul

2022-07-07 07:11:39

ADVM

Adverum Biotechnologies

$1.23 / +0.045 (+3.81%)

07:11

07/07/22

07/07

07:11

07/07/22

07:11

Truist upgrades Adverum to Buy on 'clearer development path'

Truist analyst Joon Lee upgraded Adverum Biotechnologies to Buy from Hold with a price target of $4, up from $3. The analyst now sees a "clearer development path" for ixoberogene soroparvovec in wet age-related macular degeneration. The Phaser 2 LUNA trial will dose first patient in Q3 with stream of data readouts throughout 2023, Lee tells investors in a research note. In addition, Adverum's cash runway has been extended by one year into 2025 post its restructuring, says the analyst. Lee is "relieved" to see the company's agreement with both the FDA and the European Medicines Agency on the Phase 2 trial design.

21
Jul

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Take-Two price target raised to $175 from $171 at Barclays » 05:53 08/09/22 08/09 05:53 08/09/22 05:53 TTWO Take-Two $125.49 / -1.7 (-1.34%) Barclays analyst Mario Lu… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TTWO Take-Two $125.49 / -1.7 (-1.34%) 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD 07/20/22 Take-Two's Zynga says 'Star Wars: Hunters' release delayed 07/15/22 Bandai Namco's 'Elden Ring' best selling game in U.S. in June, says NPD TTWO Take-Two $125.49 / -1.7 (-1.34%) 08/04/22 Truist Take-Two price target lowered to $162 from $175 at Truist 07/27/22 Credit Suisse Take-Two price target lowered to $139 from $182 at Credit Suisse 07/15/22 MKM Partners Take-Two is 'top idea' in video games, says MKM Partners 06/29/22 UBS Take-Two price target lowered to $143 from $185 at UBS TTWO Take-Two $125.49 / -1.7 (-1.34%) 08/08/22 Take-Two sees FY23 revenue $5.73B-$5.8B, consensus $6.32B 08/08/22 Take-Two reports Q2 EPS (76c) vs. $1.30 last year 05/16/22 Take-Two sees Q1 GAAP EPS 80c-90c, consensus 90c 05/16/22 Take-Two sees FY23 GAAP EPS $1.90-$2.15, consensus $5.99 TTWO Take-Two $125.49 / -1.7 (-1.34%) 07/21/22 Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says 07/11/22 Rockstar shelved plans for 'Red Dead 2' next-gen upgrade, VGC reports 07/05/22 Take-Two's Rockstar halts development of 'Red Dead,' 'GTA4' remakes, Kotaku says 04/14/22 'Elden Ring' top-selling game in Europe in March, Gamesindustry.biz says TTWO Take-Two $125.49 / -1.7 (-1.34%) 08/02/22 What You Missed This Week in Video Games 07/26/22 What You Missed This Week in Video Games 07/19/22 What You Missed This Week in Video Games 07/12/22 What You Missed This Week in Video Games 09/08/22 Consumer/Media/Entertainment Conference 09/16/22 Take-Two Interactive Software Inc. TTWO Take-Two $125.49 / -1.7 (-1.34%) 06/07/22 Early notable gainers among liquid option names on June 7th 05/25/22 Notable open interest changes for May 25th 05/17/22 Early notable gainers among liquid option names on May 17th 04/22/22 TakeTwo Interactive Software call volume above normal and directionally bullish
Recommendations	PowerSchool price target raised to $19 from $18 at Barclays » 05:52 08/09/22 08/09 05:52 08/09/22 05:52 PWSC PowerSchool $15.48 / -0.07 (-0.45%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PWSC PowerSchool $15.48 / -0.07 (-0.45%) 06/30/22 Middlebury Community Schools adds PowerSchool solutions 06/24/22 PowerSchool launches new products to aid students, educators 05/23/22 PowerSchool falls -10.4% 05/23/22 PowerSchool falls -15.7% PWSC PowerSchool $15.48 / -0.07 (-0.45%) 07/18/22 Piper Sandler PowerSchool price target lowered to $15 from $17 at Piper Sandler 07/13/22 Goldman Sachs PowerSchool upgraded to Neutral from Sell at Goldman Sachs 07/12/22 Barclays PowerSchool price target lowered to $18 from $20 at Barclays 03/30/22 Cantor Fitzgerald PowerSchool initiated with an Overweight at Cantor Fitzgerald PWSC PowerSchool $15.48 / -0.07 (-0.45%) 08/08/22 PowerSchool sees FY22 revenue $630M-$634M, consensus $626M 08/08/22 PowerSchool sees Q3 revenue $162M-$164M, consensus $161.92M 08/08/22 PowerSchool reports Q2 EPS 22c vs. 37c last year 05/05/22 PowerSchool raises FY22 revenue view to $623M-$627M, consensus $624.51M
Recommendations	Palo Alto Networks price target lowered to $605 from $645 at Barclays » 05:51 08/09/22 08/09 05:51 08/09/22 05:51 PANW Palo Alto Networks $500.88 / -0.11 (-0.02%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PANW Palo Alto Networks $500.88 / -0.11 (-0.02%) 07/12/22 Palo Alto Networks and HCL Technologies expand collaboration 05/25/22 Palo Alto Networks director Bawa sells $477K in company shares 05/24/22 Oracle selects Palo Alto Networks to power OCI Network Firewall 05/19/22 Palo Alto Networks jumps 10% to $478.83 after raising FY22 guidance PANW Palo Alto Networks $500.88 / -0.11 (-0.02%) 08/01/22 Wolfe Research Palo Alto Networks initiated with an Outperform at Wolfe Research 07/22/22 Citi Palo Alto Networks price target lowered to $605 from $610 at Citi 07/13/22 Piper Sandler Palo Alto Networks price target lowered to $650 from $675 at Piper Sandler 07/08/22 BMO Capital Palo Alto Networks price target raised to $650 from $615 at BMO Capital PANW Palo Alto Networks $500.88 / -0.11 (-0.02%) 05/19/22 Palo Alto Networks raises FY22 adjusted EPS view to $7.43-$7.46 from $7.23-$7.30 05/19/22 Palo Alto Networks sees Q4 adjusted EPS $2.26-$2.29, consensus $2.22 05/19/22 Palo Alto Networks reports Q3 adjusted EPS $1.79, consensus $1.68 05/19/22 Notable companies reporting after market close PANW Palo Alto Networks $500.88 / -0.11 (-0.02%) 03/14/22 Israeli government sites crash in cyberattack, Haaretz reports PANW Palo Alto Networks $500.88 / -0.11 (-0.02%) 08/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 08/22/22 Palo Alto Networks - PANW PANW Palo Alto Networks $500.88 / -0.11 (-0.02%) 05/19/22 Palo Alto Networks options imply 9.5% move in share price post-earnings 05/19/22 Unusually active option classes on open May 19th 03/23/22 Palo Alto Networks call volume above normal and directionally bullish 02/14/22 Palo Alto Networks call volume above normal and directionally bullish
Recommendations	GoodRx price target raised to $13 from $12 at Barclays » 05:50 08/09/22 08/09 05:50 08/09/22 05:50 GDRX GoodRx $7.78 / +0.715 (+10.12%) Barclays analyst Steve… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options GDRX GoodRx $7.78 / +0.715 (+10.12%) 05/17/22 GoodRx announces strategic relationship with RxVantage 05/09/22 GoodRx 'unlikely' to achieve guidance provided on Q4 earnings call 05/09/22 GoodRx names former Uber grocery, new verticals chief Raj Beri as COO 05/02/22 GoodRx partners with AssistRx GDRX GoodRx $7.78 / +0.715 (+10.12%) 07/20/22 Barclays GoodRx price target lowered to $12 from $15 at Barclays 07/18/22 Guggenheim GoodRx price target lowered to $13 from $17 at Guggenheim 06/22/22 Baird GoodRx price target lowered to $6 from $7 at Baird 06/13/22 Cowen GoodRx price target lowered to $9 from $22 at Cowen GDRX GoodRx $7.78 / +0.715 (+10.12%) 08/08/22 GoodRx sees Q3 revenue roughly $185M, consensus $201.4M 08/08/22 GoodRx reports Q2 adjusted EPS 6c, consensus 4c 08/08/22 Notable companies reporting after market close 05/09/22 GoodRx sees Q2 revenue about $190M, consensus $215.62M GDRX GoodRx $7.78 / +0.715 (+10.12%) 08/08/22 Fly Intel: After-Hours Movers 06/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 00:00 Today SMID Cap Ideas Virtual Conference GDRX GoodRx $7.78 / +0.715 (+10.12%) 05/09/22 GoodRx Holdings options imply 17.9% move in share price post-earnings
Recommendations	Americold Realty Trust price target lowered to $28 from $29 at Barclays » 05:49 08/09/22 08/09 05:49 08/09/22 05:49 COLD Americold Realty Trust $31.18 / +0.13 (+0.42%) Barclays analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly COLD Americold Realty Trust $31.18 / +0.13 (+0.42%) 06/21/22 Americold Realty Trust opens new freezer-storage facility in Dunkirk, NY 03/04/22 Americold Realty Trust eliminates position of COO 02/24/22 Americold Realty Trust appoints George Chappelle Jr. as CEO COLD Americold Realty Trust $31.18 / +0.13 (+0.42%) 08/08/22 RBC Capital Americold Realty downgraded to Sector Perform from Outperform at RBC Capital 07/07/22 Baird Americold Realty Trust price target raised to $33 from $29 at Baird 06/14/22 Barclays Americold Realty Trust price target raised to $29 from $27 at Barclays 06/02/22 BofA Americold Realty Trust upgraded to Neutral from Underperform at BofA COLD Americold Realty Trust $31.18 / +0.13 (+0.42%) 08/05/22 Americold Realty Trust reports Q2 AFFO 27, consensus 24c 05/05/22 Americold Realty Trust reports Q1 AFFO 26, consensus 24c 02/24/22 Americold Realty Trust reports Q4 FFO 26c, consensus 28c COLD Americold Realty Trust $31.18 / +0.13 (+0.42%) 06/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	Trex Company price target lowered to $53 from $63 at Barclays » 05:49 08/09/22 08/09 05:49 08/09/22 05:49 TREX Trex Company $63.74 / -0.91 (-1.41%) Barclays analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Trex Company falls 9% to $58.00 after Q2 results, below-consensus guidance 06/06/22 Trex Company provides railing solutions for University of Texas 05/16/22 Trex expands its decking line with introduction of Trex Transcend Lineage 04/28/22 Trex Company debuts Ocula, newest glass windscreen system TREX Trex Company $63.74 / -0.91 (-1.41%) 07/15/22 JPMorgan Trex Company price target lowered to $54 from $66 at JPMorgan 07/14/22 Barclays Trex Company price target lowered to $63 from $68 at Barclays 06/08/22 JPMorgan Azek valuation remains attractive versus Trex, says JPMorgan 06/03/22 Barclays Barclays continues to prefer Azek shares over Trex TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Trex Company sees Q3 revenue $180M-$190M, consensus $355.0M 08/08/22 Trex Company reports Q2 EPS 79c, consensus 68c 05/09/22 Trex Company backs FY22 revenue growth view of double-digits, consensus $1.38B 05/09/22 Trex Company sees Q2 revenue $375M-$385M, consensus $376.52M TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Fly Intel: After-Hours Movers 05/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today Jefferies Industrial Conerence
Recommendations	Oportun Financial price target lowered to $12 from $15 at Barclays » 05:48 08/09/22 08/09 05:48 08/09/22 05:48 OPRT Oportun Financial $10.77 / +0.705 (+7.01%) Barclays analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OPRT Oportun Financial $10.77 / +0.705 (+7.01%) 05/24/22 Oportun Financial relases 2021 Corporate Responsibility, Sustainability Rreport 05/24/22 Oportun Financial completes $400M asset-backed securitization OPRT Oportun Financial $10.77 / +0.705 (+7.01%) 07/11/22 Keefe Bruyette Oportun Financial price target lowered to $14 from $21 at Keefe Bruyette 07/11/22 Barclays Oportun Financial price target lowered to $15 from $27 at Barclays 06/06/22 Loop Capital Oportun Financial in unique position for big upside, says Loop Capital 03/14/22 Loop Capital Oportun Financial initiated with a Buy at Loop Capital OPRT Oportun Financial $10.77 / +0.705 (+7.01%) 08/08/22 Oportun Financial sees FY22 adjusted EPS $1.19-$1.34, consensus $2.49 08/08/22 Oportun Financial sees Q3 EPS (12c)-(6c), consensus 27c 08/08/22 Oportun Financial reports Q2 EPS 11c, consensus 9c 05/09/22 Oportun Financial reports Q1 EPS $1.58, consensus 59c
Recommendations	MacroGenics price target lowered to $8 from $18 at Barclays » 05:47 08/09/22 08/09 05:47 08/09/22 05:47 MGNX MacroGenics $4.52 / +0.135 (+3.08%) Barclays analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MGNX MacroGenics $4.52 / +0.135 (+3.08%) 07/08/22 MacroGenics announces closure of CP-MGA271-06 study 06/27/22 Zymeworks appoints Paul Moore as Chief Scientific Officer 02/28/22 MacroGenics promotes Eric Riser to COO MGNX MacroGenics $4.52 / +0.135 (+3.08%) 07/11/22 BTIG MacroGenics price target lowered to $6 at BTIG 07/11/22 BMO Capital MacroGenics downgraded to Market Perform from Outperform at BMO Capital 05/05/22 Guggenheim MacroGenics downgraded to Neutral yesterday at Guggenheim 05/04/22 Guggenheim MacroGenics downgraded to Neutral from Buy at Guggenheim MGNX MacroGenics $4.52 / +0.135 (+3.08%) 08/08/22 MacroGenics reports Q2 EPS (67c), consensus (97c)
Downgrade	Professional Holding downgraded to Market Perform on buyout at Raymond James » 05:46 08/09/22 08/09 05:46 08/09/22 05:46 PFHD Professional Holding $29.65 / +6.58 (+28.52%) , SBCF Seacoast Banking $34.58 / -2.16 (-5.88%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PFHD SBCF PFHD Professional Holding $29.65 / +6.58 (+28.52%) 08/08/22 Seacoast Banking to acquire Professional Holding for $488.6M 08/08/22 Seacoast Banking to acquire Professional Holding in $488.6M transaction 02/24/22 Professional Holding names Abel Iglesias as CEO SBCF Seacoast Banking $34.58 / -2.16 (-5.88%) 08/08/22 Seacoast Banking to acquire Professional Holding for $488.6M 08/08/22 Seacoast Banking to acquire Professional Holding in $488.6M transaction 05/04/22 Seacoast Banking to acquire Drummond Banking in deal valued at $173.2M 04/19/22 Seacoast Banking raises quarterly dividend to 17c from 13c per share PFHD SBCF PFHD Professional Holding $29.65 / +6.58 (+28.52%) 05:04 Today Raymond James Professional Holding downgraded to Market Perform at Raymond James 05/09/22 Piper Sandler Professional Holding downgraded to Neutral from Overweight at Piper Sandler SBCF Seacoast Banking $34.58 / -2.16 (-5.88%) 07/11/22 B. Riley Seacoast Banking price target lowered to $34 from $36 at B. Riley 07/06/22 Truist Seacoast Banking price target lowered to $39 from $42 at Truist 01/17/22 Keefe Bruyette Seacoast Banking initiated with a Market Perform at Keefe Bruyette 10/06/21 B. Riley Seacoast Banking downgraded to Neutral from Buy at B. Riley PFHD SBCF PFHD Professional Holding $29.65 / +6.58 (+28.52%) 07/28/22 Professional Holding reports Q2 EPS 50c consensus 38c 04/29/22 Professional Holding reports Q1 EPS 18c, consensus 34c SBCF Seacoast Banking $34.58 / -2.16 (-5.88%) 07/28/22 Seacoast Banking reports Q2 EPS 53c, consensus 53c 04/28/22 Seacoast Banking reports Q1 EPS 44c, consensus 42c 08/11/22 Seacoast Banking 08/12/22 Seacoast Banking
Periodicals	Samsung plans $3.3B investment in Vietnam, South China Morning Post reports » 05:45 08/09/22 08/09 05:45 08/09/22 05:45 SSNLF Samsung $57.75 / + (+0.00%) Samsung plans to make an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SSNLF Samsung $57.75 / + (+0.00%) 07/28/22 Samsung Display segment Q2 earnings 'solid despite weak seasonality' 07/27/22 Qualcomm, Samsung extend, expand strategic partnership 06/30/22 Samsung begins chip production using 3nm process technology 06/09/22 Microsoft, Samsung partner to bring Xbox Cloud Gaming to Samsung Smart TVs SSNLF Samsung $57.75 / + (+0.00%) 06/22/22 Loop Capital Samsung initiated with a Buy at Loop Capital 06/13/22 KeyBanc Qualcomm price target raised to $220 from $200 at KeyBanc 06/13/22 UBS Micron price target lowered to $115 from $120 at UBS 06/01/22 Craig-Hallum Ambarella price target lowered to $100 from $170 at Craig-Hallum SSNLF Samsung $57.75 / + (+0.00%) 07/28/22 Samsung reports Q2 EPS KRW 1,613 vs. KRW 1,391 last year 07/06/22 Samsung sees Q2 operating profit KRW14.0T vs. KRW14.6T consensus 04/28/22 Samsung reports Q1 EPS KRW 1,638 vs. KRW 1,044 last year 04/06/22 Samsung sees Q1 operating profit KRW14.1T vs. KRW13.4T consensus SSNLF Samsung $57.75 / + (+0.00%) 08/03/22 Samsung rethinking China exposure amid Chips and Science Act, FT reports 07/21/22 Samsung considering building 11 chipmaking facility, American-Statesman reports 07/18/22 Samsung may hold latest foldable launch event on August 10, Verge says 06/28/22 Samsung Display buys OLED startup Cynora for about $300M, Bloomberg says SSNLF Samsung $57.75 / + (+0.00%) 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed This Week in Video Games 06/14/22 What You Missed This Week in Video Games

Recommendations	Bandwidth price target lowered to $19 from $20 at Citi » 05:44 08/09/22 08/09 05:44 08/09/22 05:44 BAND Bandwidth $16.95 / +0.915 (+5.71%) Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BAND Bandwidth $16.95 / +0.915 (+5.71%) 06/22/22 Bandwidth, Alianza announce partnership 06/02/22 Bandwidth appoints Karl Perkins as Chief Innovation Officer 03/29/22 Bandwidth appoints Sandy Preizler as Chief Revenue Officer 03/21/22 Bandwidth announces partnership and integration with Pindrop BAND Bandwidth $16.95 / +0.915 (+5.71%) 08/04/22 Canaccord Bandwidth price target lowered to $50 from $71 at Canaccord 08/04/22 JMP Securities Bandwidth price target lowered to $55 from $100 at JMP Securities 07/26/22 Barclays Bandwidth price target lowered to $30 from $45 at Barclays 07/13/22 Piper Sandler Bandwidth price target lowered to $29 from $40 at Piper Sandler BAND Bandwidth $16.95 / +0.915 (+5.71%) 08/03/22 Bandwidth sees FY22 non-GAAP EPS 10c-14c, consensus 12c 08/03/22 Bandwidth sees Q3 non-GAAP EPS 2c-4c, consensus 2c 08/03/22 Bandwidth reports Q2 non-GAAP EPS (4c), consensus (6c) 05/04/22 Bandwidth sees 2022 non-GAAP EPS 10c-14c, consensus 7c BAND Bandwidth $16.95 / +0.915 (+5.71%) 05/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/04/22 Fly Intel: After-Hours Movers 02/23/22 Fly Intel: After-Hours Movers
Periodicals	Amazon's iRobot, One Medical deals show hunt for fourth 'pillar,' Bloomberg says » 05:44 08/09/22 08/09 05:44 08/09/22 05:44 AMZN Amazon.com $139.42 / -1.37 (-0.97%) , IRBT iRobot $59.58 / +0.07 (+0.12%) , ONEM 1Life Healthcare $16.85 / -0.12 (-0.71%) Amazon's (AMZN)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN IRBT ONEM AMZN Amazon.com $139.42 / -1.37 (-0.97%) 08/05/22 iRobot to be acquired by Amazon for $61/share in deal valued at $1.7B 08/05/22 Amazon to acquire iRobot for $61.00 per share in cash 08/05/22 iRobot to be acquired by Amazon for $61/share in deal valued at $1.7B 08/02/22 Kaplan, Amazon partner for career, student support services IRBT iRobot $59.58 / +0.07 (+0.12%) 08/05/22 iRobot trading to resume at 8:30 am ET 08/05/22 iRobot to be acquired by Amazon for $61/share in deal valued at $1.7B 08/05/22 Amazon to acquire iRobot for $61.00 per share in cash 08/05/22 iRobot to be acquired by Amazon for $61/share in deal valued at $1.7B ONEM 1Life Healthcare $16.85 / -0.12 (-0.71%) 07/21/22 Cano Health, Oak Street rally after Amazon buys One Medical 07/21/22 Teladoc down 9% after Amazon agrees to acquire One Medical 07/21/22 1Life Healthcare trading resumes 07/21/22 1Life Healthcare to resume trading at 9:00 am ET AMZN IRBT ONEM AMZN Amazon.com $139.42 / -1.37 (-0.97%) 08/08/22 B. Riley B. Riley thinks Globalstar's mystery satellite capacity customer is Apple 08/05/22 DA Davidson Amazon may be be more willing to do M&A under Jassy, says DA Davidson 07/29/22 UBS Amazon.com price target raised to $180 from $167 at UBS 07/29/22 BofA Amazon price target bumped to $170 at BofA after 'mostly positive' quarter IRBT iRobot $59.58 / +0.07 (+0.12%) 08/08/22 Northland iRobot downgraded to Market Perform from Outperform at Northland 08/05/22 DA Davidson Amazon may be be more willing to do M&A under Jassy, says DA Davidson 07/14/22 Citi Citi cuts iRobot target, opens 'negative 30-day catalyst watch' 05/06/22 JPMorgan iRobot downgraded to Underweight on risks to guidance at JPMorgan ONEM 1Life Healthcare $16.85 / -0.12 (-0.71%) 08/05/22 DA Davidson Amazon may be be more willing to do M&A under Jassy, says DA Davidson 07/27/22 Stifel Oak Street Health price target raised to $35 from $25 at Stifel 07/27/22 Stifel 1Life Healthcare downgraded to Hold from Buy at Stifel 07/25/22 Truist 1Life Healthcare downgraded to Hold from Buy at Truist AMZN IRBT ONEM AMZN Amazon.com $139.42 / -1.37 (-0.97%) 07/28/22 Amazon reports Q2 AWS net sales $19.73B vs. $14.81B a year ago 07/28/22 Amazon sees Q3 revenue $125B-$130B, consensus $126.42B 07/28/22 Amazon reports Q2 EPS (20c) with Rivian loss, consensus 13c 07/28/22 Notable companies reporting after market close IRBT iRobot $59.58 / +0.07 (+0.12%) 08/05/22 iRobot withdraws and suspends guidance 08/05/22 iRobot reports Q2 non-GAAP EPS (35c), consensus ($1.55) 05/04/22 iRobot widens FY22 non-GAAP EPS $1.50-$2.10 from $1.50-$2.00, consensus $1.59 05/04/22 iRobot reports Q1 non-GAAP EPS (66c), consensus ($1.35) ONEM 1Life Healthcare $16.85 / -0.12 (-0.71%) 08/03/22 1Life Healthcare reports Q2 EPS (48c), consensus (48c) 05/04/22 1Life Healthcare sees FY22 revenue $1.055B-$1.095B, consensus $1.07B 05/04/22 1Life Healthcare sees Q2 revenue $255M-$270M, consensus $263.36M 05/04/22 1Life Healthcare reports Q1 EPS (47c), consensus (49c) AMZN ONEM AMZN Amazon.com $139.42 / -1.37 (-0.97%) 08/08/22 Amazon in early talks for 51% stake in Ecom Express, Mint says 08/04/22 Union says hundreds of U.K. Amazon warehouse workers walk out, Reuters says 08/01/22 Amazon hires senior congressional aide to fight antitrust bill, Bloomberg says 07/31/22 Indonesia blocks Yahoo, PayPal over license breaches, Reuters reports ONEM 1Life Healthcare $16.85 / -0.12 (-0.71%) 07/05/22 1Life Healthcare weighs options after drawing takeover interest, Bloomberg says 07/05/22 1Life Healthcare weighs options after drawing takeover interest, Bloomberg says 03/08/22 Lawmakers considering extending telehealth policies, STATNews reports AMZN IRBT ONEM AMZN Amazon.com $139.42 / -1.37 (-0.97%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/06/22 Opening Day: Magic Empire opening surge calls to mind AMTD Digital frenzy 08/05/22 What You Missed On Wall Street On Friday IRBT iRobot $59.58 / +0.07 (+0.12%) 08/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/05/22 What You Missed On Wall Street On Friday 08/05/22 What You Missed On Wall Street This Morning 08/05/22 Fly Intel: Pre-market Movers ONEM 1Life Healthcare $16.85 / -0.12 (-0.71%) 07/28/22 Here's what Wall St. experts are saying about Amazon ahead of earnings 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/07/22 What You Missed On Wall Street On Thursday 10/09/22 64th NABE Annual Meeting 08/10/22 iRobot - IRBT AMZN IRBT ONEM AMZN Amazon.com $139.42 / -1.37 (-0.97%) 08/05/22 Notable open interest changes for August 5th 08/04/22 Notable open interest changes for August 4th 08/02/22 Notable open interest changes for August 2nd 08/01/22 Notable open interest changes for August 1st IRBT iRobot $59.58 / +0.07 (+0.12%) 02/09/22 iRobot options imply 12.5% move in share price post-earnings ONEM 1Life Healthcare $16.85 / -0.12 (-0.71%) 07/25/22 1Life Healthcare call volume above normal and directionally bullish 05/04/22 1Life Healthcare options imply 17.3% move in share price post-earnings 02/23/22 1Life Healthcare options imply 18.1% move in share price post-earnings
Recommendations	MediaAlpha price target lowered to $12 from $15 at Citi » 05:44 08/09/22 08/09 05:44 08/09/22 05:44 MAX MediaAlpha $9.37 / -0.54 (-5.45%) Citi analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MAX MediaAlpha $9.37 / -0.54 (-5.45%) 08/05/22 MediaAlpha falls -16.9% 03/14/22 MediaAlpha announces $5M share repurchase program MAX MediaAlpha $9.37 / -0.54 (-5.45%) 05/13/22 RBC Capital MediaAlpha price target lowered to $13 from $18 at RBC Capital 03/10/22 RBC Capital MediaAlpha price target lowered to $18 from $24 at RBC Capital 02/25/22 Canaccord MediaAlpha price target lowered to $20 from $30 at Canaccord 02/23/22 Citi MediaAlpha downgraded to Neutral from Buy at Citi MAX MediaAlpha $9.37 / -0.54 (-5.45%) 08/04/22 MediaAlpha sees Q3 revenue $77M-$87M, consensus $144.25M 08/04/22 MediaAlpha reports Q2 EPS (22c), consensus (17c) 05/05/22 MediaAlpha sees Q2 revenue $110M-$120M, consensus $156.45M 05/05/22 MediaAlpha reports Q1 EPS (17c), consensus (7c)
Recommendations	Valvoline price target lowered to $35 from $37 at Citi » 05:42 08/09/22 08/09 05:42 08/09/22 05:42 VVV Valvoline $28.86 / +0.175 (+0.61%) Citi analyst Chasen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events VVV Valvoline $28.86 / +0.175 (+0.61%) 08/01/22 Valvoline to sell global products business to Aramco for $2.65B in cash 06/16/22 Valvoline expands service strategy to include heavy-duty vehicles 05/25/22 Valvoline extends rally, shares up 21% to $36.13 after WSJ report 05/25/22 Valvoline trading resumes VVV Valvoline $28.86 / +0.175 (+0.61%) 08/03/22 Citi Valvoline price target raised to $37 from $35 at Citi 06/16/22 Jefferies Valvoline price target lowered to $40 from $44 at Jefferies 05/26/22 Jefferies Deal for all of Valvoline doesn't appear to be Aramco focus, says Jefferies 05/12/22 JPMorgan Valvoline upgraded to Overweight on valuation at JPMorgan VVV Valvoline $28.86 / +0.175 (+0.61%) 08/03/22 Valvoline narrows FY22 adjusted EPS view to $2.07-$2.15 from $2.07-$2.20 08/03/22 Valvoline reports Q3 adjusted EPS 58c, consensus 56c 08/01/22 Valvoline reports preliminary Q3 adjusted EPS 58c, consensus 56c 05/09/22 Valvoline reaffrims FY22 adjusted EPS view $2.07-$2.20, consensus $2.30 VVV Valvoline $28.86 / +0.175 (+0.61%) 05/25/22 Valvoline tells Reuters 'rigorous process in place,' no decisions have been made 05/25/22 Valvoline jumps after WSJ says Saudi Aramco made takeover approach 05/25/22 Aramco approached Valvoline about takeover, WSJ reports VVV Valvoline $28.86 / +0.175 (+0.61%) 08/01/22 What You Missed On Wall Street On Monday 08/01/22 What You Missed On Wall Street This Morning 08/01/22 Fly Intel: Pre-market Movers 05/25/22 What You Missed On Wall Street On Wednesday 08/10/22 Valvoline
Recommendations	GrafTech price target lowered to $7.50 from $10 at Citi » 05:40 08/09/22 08/09 05:40 08/09/22 05:40 EAF GrafTech $6.67 / -0.29 (-4.17%) Citi analyst Alexander… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EAF GrafTech $6.67 / -0.29 (-4.17%) 07/13/22 GrafTech falls -8.3% 07/13/22 GrafTech falls -9.0% 06/28/22 GrafTech names Marcel Kessler as CEO 05/06/22 GrafTech says 'overall fundamentals in the steel industry are strong' EAF GrafTech $6.67 / -0.29 (-4.17%) 07/13/22 RBC Capital RBC Capital cuts GrafTech to Sector Perform amid reduced long-term pricing terms 07/13/22 RBC Capital GrafTech downgraded to Sector Perform from Outperform at RBC Capital 06/07/22 Citi GrafTech downgraded to Neutral at Citi on lack of near-term catalysts 06/07/22 Citi GrafTech downgraded to Neutral from Buy at Citi EAF GrafTech $6.67 / -0.29 (-4.17%) 08/05/22 GrafTech reports Q2 adjusted EPS 44c, consensus 43c 05/06/22 GrafTech reports Q1 adjusted EPS 48c, consensus 44c EAF GrafTech $6.67 / -0.29 (-4.17%) 06/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	Acadia Pharmaceuticals price target raised to $17 from $15 at Citi » 05:40 08/09/22 08/09 05:40 08/09/22 05:40 ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) Citi analyst Neena… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 08/05/22 Acadia Pharmaceuticals receives CRL from FDA regarding Nuplazid sNDA 07/18/22 Acadia Pharmaceuticals submits NDA to FDA for Rett Syndrome treatment 06/21/22 Acadia Pharmaceuticals down 30% after FDA AdCom vote against Nuplazid 06/18/22 Acadia 'disappointed' with PDAC vote of 9 to 3 against Nuplazid in ADP ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 08/08/22 Cowen Acadia Pharmaceuticals price target lowered to $21 from $32 at Cowen 08/05/22 Citi Acadia Pharmaceuticals downgraded to Neutral from Buy at Citi 06/22/22 Canaccord Acadia Pharmaceuticals price target lowered to $20 from $31 at Canaccord 06/22/22 Citi Acadia Pharmaceuticals price target lowered to $19 from $32 at Citi ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 08/08/22 Acadia Pharmaceuticals narrows FY22 revenue view to $510M-$540M from $510M-$560M 08/08/22 Acadia Pharmaceuticals reports Q2 EPS (21c), consensus (25c) 05/04/22 Acadia Pharmaceuticals backs FY22 revenue view of $510M-$560M, consensus $540.7M 05/04/22 Acadia Pharmaceuticals reports Q1 EPS (70c), consensus (60c) ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 06/16/22 What You Missed On Wall Street On Thursday ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 07/15/22 Acadia call volume above normal and directionally bullish 07/12/22 Acadia call volume above normal and directionally bullish 06/15/22 Unusually active option classes on open June 15th 05/04/22 Acadia options imply 19.6% move in share price post-earnings
Recommendations	Clover Health price target raised to $3.50 from $3 at Citi » 05:39 08/09/22 08/09 05:39 08/09/22 05:39 CLOV Clover Health $3.40 / +0.14 (+4.30%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options CLOV Clover Health $3.40 / +0.14 (+4.30%) 08/08/22 Clover Health CEO Vivek Garipalli to switch roles, Andrew Toy to succeed 07/14/22 Clover Health announces planned medicare edvantage expansion for 2023 06/24/22 Clover Health is set to join the Russell 3000 Index 05/25/22 Clover Health appoints Scott Leffler as CFO CLOV Clover Health $3.40 / +0.14 (+4.30%) 02/24/22 Canaccord Clover Health price target raised to $7 from $6 at Canaccord 02/17/22 Citi Citi opens 'negative catalyst watches' in health care services 02/02/22 Cowen Clover Health upgraded to Market Perform from Underperform at Cowen 01/19/22 SVB Leerink Clover Health initiated with a Market Perform at SVB Leerink CLOV Clover Health $3.40 / +0.14 (+4.30%) 08/08/22 Clover Health reports Q2 revenue $846.7M, consensus $814.62M 05/09/22 Clover Health reaffirms FY22 revenue view $3.0B-$3.4B, consensus $3.24B 05/09/22 Clover Health reports Q1 revenue $874.4M, consensus $787.41M 02/23/22 Clover Health sees FY22 revenue $3.0B-$3.4B, consensus $2.62B 18 Nov CLOV Clover Health $3.40 / +0.14 (+4.30%) 05/10/22 Fly Intel: Pre-market Movers 05/09/22 Fly Intel: After-Hours Movers 02/24/22 What You Missed On Wall Street On Thursday 02/24/22 What You Missed On Wall Street This Morning CLOV Clover Health $3.40 / +0.14 (+4.30%) 08/08/22 Clover Health options imply 12.4% move in share price post-earnings 07/18/22 Unusually active option classes on open July 18th 06/27/22 Unusually active option classes on open June 27th 06/21/22 Unusually active option classes on open June 21st
Recommendations	Palantir price target lowered to $6 from $7 at Citi » 05:38 08/09/22 08/09 05:38 08/09/22 05:38 PLTR Palantir $9.82 / -1.625 (-14.20%) Citi analyst Tyler Radke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PLTR Palantir $9.82 / -1.625 (-14.20%) 08/08/22 Palantir falls -12.0% 08/08/22 Palantir falls -14.4% 08/08/22 Palantir falls -12.2% 07/28/22 Palantir announces $99.9M contract with U.S. Army Research Laboratory PLTR Palantir $9.82 / -1.625 (-14.20%) 05:18 Today Deutsche Bank Palantir downgraded to Sell from Hold at Deutsche Bank 08/08/22 Jefferies Palantir price target lowered to $12 from $13 at Jefferies 08/03/22 RBC Capital U.S. federal spending tracker 'worrisome' for Palantir, says RBC Capital 07/22/22 Monness Crespi Monness downgrades Palantir, says recent rally may be unsustainable PLTR Palantir $9.82 / -1.625 (-14.20%) 08/08/22 Palantir sees FY22 revenue $1.9B - $1.902B , consensus $1.96B 08/08/22 Palantir sees Q3 revenue $474M - $475M , consensus $506.88M 08/08/22 Palantir reports Q2 EPS (9c) vs. (7c) last year 05/09/22 Palantir sees Q2 revenue base case $470M, consensus $483.84M PLTR Palantir $9.82 / -1.625 (-14.20%) 08/05/22 Palantir tells Bloomberg headcount to rise about 25% by end of year 04/04/22 Morgan Stanley hit with FINRA arbitration demand over Palantir, WSJ reports PLTR Palantir $9.82 / -1.625 (-14.20%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday PLTR Palantir $9.82 / -1.625 (-14.20%) 07/26/22 Palantir Technologies put volume heavy and directionally bearish 07/21/22 Unusually active option classes on open July 21st 06/24/22 Unusually active option classes on open June 24th 06/21/22 Unusually active option classes on open June 21st
Recommendations	RBC Bearings price target raised to $250 from $200 at Citi » 05:37 08/09/22 08/09 05:37 08/09/22 05:37 ROLL RBC Bearings $243.51 / +3.22 (+1.34%) Citi analyst Timothy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate Events ROLL RBC Bearings $243.51 / +3.22 (+1.34%) 07/19/22 Truist RBC Bearings price target lowered to $235 from $250 at Truist 06/23/22 BofA RBC Bearings downgraded to Neutral on valuation at BofA 06/23/22 BofA RBC Bearings downgraded to Neutral from Buy at BofA 03/11/22 Wells Fargo RBC Bearings initiated with an Overweight at Wells Fargo ROLL RBC Bearings $243.51 / +3.22 (+1.34%) 08/04/22 RBC Bearings reports Q1 EPS $1.19 vs. 96c last year 05/26/22 RBC Bearings sees Q1 revenue $355M-$365M, consensus $351.06M 05/26/22 RBC Bearings reports Q4 adjusted EPS $1.26, consensus $1.14 02/10/22 RBC Bearings sees Q4 revenue $340M-$350M, consensus $344.76M 22 Sep 09/08/22 RBC Bearings Inc.
Recommendations	TaskUs price target lowered to $23 from $28 at Citi » 05:36 08/09/22 08/09 05:36 08/09/22 05:36 TASK TaskUs $23.49 / +0.565 (+2.47%) Citi analyst Ryan Potter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TASK TaskUs $23.49 / +0.565 (+2.47%) 07/11/22 TaskUs, Tamil Nadu government sign MoU for Technology Center of Excellence 04/19/22 TaskUs acquires heloo, terms undisclosed 03/17/22 TaskUs announces office expansions in Japan, the U.S. 03/09/22 TaskUs appoints Gonzalez, Greenthal to board expanding it to nine members TASK TaskUs $23.49 / +0.565 (+2.47%) 07/20/22 JPMorgan TaskUs price target lowered to $35 from $41 at JPMorgan 07/19/22 Citi TaskUs initiated with a Buy at Citi 06/30/22 Morgan Stanley TaskUs price target lowered to $28 from $35 at Morgan Stanley 05/10/22 BTIG TaskUs price target lowered to $45 from $60 at BTIG TASK TaskUs $23.49 / +0.565 (+2.47%) 08/08/22 TaskUs reports Q2 adjusted EPS 38c vs 32c last year 05/09/22 TaskUs reaffirms FY22 revenue view $980M-$1.0B, consensus $993.43M 05/09/22 TaskUs sees Q2 revenue $241.5M-$243.5M, consensus $239.39M 05/09/22 TaskUs reports Q1 adjusted EPS 34c, consensus 32c 21 Oct TASK TaskUs $23.49 / +0.565 (+2.47%) 08/08/22 Fly Intel: After-Hours Movers 07/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/22 Fly Intel: After-Hours Movers

Recommendations	eHealth price target lowered to $9 from $13 at Citi » 05:35 08/09/22 08/09 05:35 08/09/22 05:35 EHTH eHealth $8.29 / +0.52 (+6.69%) Citi analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EHTH eHealth $8.29 / +0.52 (+6.69%) 03/01/22 eHealth sinks 22% to $12.05 after Q4 results miss estimates 03/01/22 eHealth CEO 'implementing a number of changes' 03/01/22 eHealth plans 'multi-year transformation initiative' 02/28/22 eHealth appoints Roman Rariy as COO, CTO EHTH eHealth $8.29 / +0.52 (+6.69%) 05/05/22 Deutsche Bank eHealth price target lowered to $10 from $19 at Deutsche Bank 03/31/22 Credit Suisse eHealth assumed with a Neutral at Credit Suisse 03/21/22 Citi eHealth downgraded to Neutral from Buy at Citi 03/03/22 Credit Suisse eHealth price target lowered to $16 from $31 at Credit Suisse EHTH eHealth $8.29 / +0.52 (+6.69%) 08/08/22 eHealth reports Q2 adjusted EPS ($1.15), consensus ($1.15) 08/08/22 eHealth cuts FY revenue view to $375M-$395M from $448M-$470M 05/03/22 eHealth sees FY22 revenue $448M-$470M, consensus $456.6M 05/03/22 eHealth reports Q1 adjusted EPS (91c), consensus ($1.19) EHTH eHealth $8.29 / +0.52 (+6.69%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Downgrade	Crispr Therapeutics downgraded to Equal Weight from Overweight at Barclays » 05:33 08/09/22 08/09 05:33 08/09/22 05:33 CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) Barclays analyst Gena… Barclays analyst Gena Wang downgraded Crispr Therapeutics to Equal Weight from Overweight with a price target of $88, down from $99. The company's Q2 release was "largely incremental," highlighting the progress of its multiple clinical programs, Wang tells investors in a research note. The analyst is stepping to the sidelines "given some questions on durability" of the allogeneic CAR-T programs and lack of other major data catalysts in the next 12 months. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 06/21/22 Crispr Therapeutics down 11% as Virtual Innovation Day continues 06/13/22 Cathie Wood's ARK Investment bought 89K shares of Crispr Therapeutics today 06/12/22 Crispr Therapeutics presents results from Phase 1 COBALT-LYM trial of CTX130 06/12/22 Vertex, Crispr Therapeutics present new data on exa-cel CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 08/08/22 Chardan Crispr Therapeutics price target lowered to $154 from $164 at Chardan 08/02/22 Citi Crispr Therapeutics price target raised to $83 from $53 at Citi 06/23/22 Oppenheimer Crispr Therapeutics price target lowered to $122 from $150 at Oppenheimer 06/23/22 Evercore ISI Crispr Therapeutics downgraded to In Line from Outperform at Evercore ISI CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 08/08/22 Crispr Therapeutics reports Q2 EPS ($2.40), consensus ($2.23) 05/09/22 Crispr Therapeutics reports Q1 EPS ($2.32), consensus ($1.94) 02/15/22 Crispr Therapeutics reports Q4 EPS ($1.84), consensus ($1.77) CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 07/25/22 Researchers warn CRISPR gene editing may trigger cancer, Jerusalem Post says CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 06/22/22 What You Missed On Wall Street On Wednesday 06/22/22 What You Missed On Wall Street This Morning 06/17/22 What You Missed On Wall Street On Friday 06/17/22 What You Missed On Wall Street This Morning CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 07/28/22 Crispr Therapeutics options imply 3.9% move in share price post-earnings 05/20/22 Largest borrow rate increases among liquid names 04/26/22 Crispr Therapeutics options imply 5.6% move in share price post-earnings
Downgrade	RPS Group downgraded to Hold from Buy at Liberum » 05:32 08/09/22 08/09 05:32 08/09/22 05:32 RPSGF RPS Group $1.30 / + (+0.00%) Liberum analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RPSGF RPS Group $1.30 / + (+0.00%) 06/27/22 Berenberg RPS Group price target raised to 150 GBp from 145 GBp at Berenberg 03/17/22 RBC Capital RPS Group price target raised to 135 GBp from 130 GBp at RBC Capital
Downgrade	Nike downgraded to Neutral from Outperform at Exane BNP Paribas » 05:30 08/09/22 08/09 05:30 08/09/22 05:30 NKE Nike $114.01 / +0.13 (+0.11%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NKE Nike $114.01 / +0.13 (+0.11%) 07/27/22 CarGurus appoints Javier Zamora as general counsel 07/19/22 Skechers down 4% as short-seller Spruce Point sees 30%-50% downside risk 06/27/22 Nike says taking 'cautious approach' to greater China in FY23 06/27/22 Nike says digital now represents 24% of brand revenue NKE Nike $114.01 / +0.13 (+0.11%) 07/25/22 Piper Sandler Nike assumed with a Neutral at Piper Sandler 07/21/22 KeyBanc KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view 07/20/22 KeyBanc Nike initiated with a Sector Weight at KeyBanc 07/20/22 Stifel Nike price target lowered to $130 from $135 at Stifel NKE Nike $114.01 / +0.13 (+0.11%) 06/27/22 Nike sees Q1 revenue growth flat to slightly up sequentially, consensus $12.88B 06/27/22 Nike sees FY23 revenue growth in low double digits, consensus $51.57B 06/27/22 Nike reports Q4 EPS 90c, consensus 81c 06/27/22 Notable companies reporting after market close NKE Nike $114.01 / +0.13 (+0.11%) 06/23/22 Cisco, Nike planning to fully exit Russia, Reuters reports 05/24/22 Nike not renewing franchise deal with IRG, will leave Russia, Vedomosti says 05/18/22 Nike's head of diversity to leave at end of July, FT reports 03/19/22 Nike reports earnings Monday, investors shouldn't get hopes up, Barron's says NKE Nike $114.01 / +0.13 (+0.11%) 07/11/22 Game On: Wedbush's Pachter calls GameStop chairman 'deluded' 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 06/28/22 Fly Intel: Pre-market Movers 09/09/22 Nike Inc. NKE Nike $114.01 / +0.13 (+0.11%) 07/05/22 Early notable gainers among liquid option names on July 5th 06/29/22 Early notable gainers among liquid option names on June 29th 06/27/22 Nike options imply 8.0% move in share price post-earnings 06/27/22 Unusually active option classes on open June 27th
Initiation	RMR Group assumed with a Perform at Oppenheimer » 05:29 08/09/22 08/09 05:29 08/09/22 05:29 RMR RMR Group $28.45 / -0.065 (-0.23%) Oppenheimer analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RMR RMR Group $28.45 / -0.065 (-0.23%) 04/14/22 RMR Group raises quarterly dividend 5.3% to 40c per share 03/14/22 Industrial Logistics Property Trust names Yael Duffy COO RMR RMR Group $28.45 / -0.065 (-0.23%) 05/20/22 RBC Capital RMR Group price target lowered to $32 from $36 at RBC Capital 05/13/22 B. Riley RMR Group price target raised to $44 from $42 at B. Riley 01/31/22 B. Riley RMR Group price target lowered to $42 from $44 at B. Riley 12/01/21 RBC Capital RMR Group price target lowered to $35 from $42 at RBC Capital RMR RMR Group $28.45 / -0.065 (-0.23%) 08/05/22 RMR Group sees Q4 adjusted EPS 57c-60c, consensus 57c 08/04/22 RMR Group reports Q3 adjusted EPS 59c, consensus 58c 05/05/22 RMR Group sees Q3 adjusted EPS 57-60c, consensus 48c 05/04/22 RMR Group reports Q2 adjusted EPS 50c, consensus 48c

Events

Earnings calls, analyst events, roadshows and more

Today at 06:00

NFIB Small Business Optimism Index: July 2022 Government Event
XYF
Today at 07:00

X Financial - XYF Conference Calls
LMND
Today at 08:00

Lemonade - LMND Conference Calls
AXSM
Today at 08:00

Axsome Therapeutics - AXSM Conference Calls
KPLT
Today at 08:00

Katapult - KPLT Conference Calls
KLTR
Today at 08:00

Kaltura - KLTR Conference Calls
SDC
Today at 08:00

SmileDirectClub - SDC Conference Calls
AVDL
Today at 08:00

Avadel Pharmaceuticals - AVDL Conference Calls
REYN
Today at 08:00

Reynolds Consumer Products - REYN Conference Calls
ACM
Today at 08:00

Aecom - ACM Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley $25.99 10.808M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55 PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist $12.40-12.70
Tues	CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler $35.00 6M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Truist upgrades Adverum to Buy on 'clearer development path'

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access